Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

To investigate the effect of antidiabetic agents on nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM), 75 patients with T2DM and NAFLD under inadequate glycemic control by metformin were randomized (1:1:1) to receive add‐on liraglutide, sitagliptin, or insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jinhua, Yao, Bin, Kuang, Hongyu, Yang, Xubin, Huang, Qin, Hong, Tianpei, Li, Yushu, Dou, Jingtao, Yang, Wenying, Qin, Guijun, Yuan, Huijuan, Xiao, Xinhua, Luo, Sihui, Shan, Zhongyan, Deng, Hongrong, Tan, Ying, Xu, Fen, Xu, Wen, Zeng, Longyi, Kang, Zhuang, Weng, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594101/
https://www.ncbi.nlm.nih.gov/pubmed/30341767
http://dx.doi.org/10.1002/hep.30320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594101/
https://www.ncbi.nlm.nih.gov/pubmed/30341767
http://dx.doi.org/10.1002/hep.30320

Ejemplares similares